- Best Wishes
- A Leader in the Fight Against Antimicrobial Resistance
News
bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide.
Swipe to discover more
-
WellStreet Urgent Care, bioMérieux celebrate 200,000 patients served through BIOFIRE® SPOTFIRE® tests in urgent care clinics across Georgia, Ohio and South Carolina
WellStreet Urgent Care and bioMérieux announce the 200,000th patient diagnosed via the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini in their urgent clinics since the first instrument placement in February 2025. -
Fast Antimicrobial Susceptibility Testing
In this article, we delve into the benefits of fast AST and explore why it has the potential to bridge the critical gap in BSI and sepsis management. -
Food Safety Trends Building Momentum into 2026
As 2026 begins, bioMérieux proudly continues our tradition of looking into the next twelve months and analyzing how key food safety trends will influence the food supply chain and our partners’ operations. The three identified trends for 2026 will continue to develop and inform food safety and quality standards — standards that we at bioMérieux are proud to help pioneer and contribute to.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19